Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Abernethy

Showing results (91-100 of 221) with videos related to

Pageof 23
Sort By:
The New England Journal of Medicine|August 11, 1983
Drug therapy. Current status of benzodiazepinesD J Greenblatt, R I Shader, D R Abernethy
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1985
Imipramine and desipramine disposition in the elderlyD R Abernethy, D J Greenblatt, R I Shader
Clinical Pharmacology and Therapeutics|May 1, 1987
The effect of propylene glycol on antipyrine clearance in humansE B Nelson, J M Egan, D R Abernethy
Therapeutic Drug Monitoring|January 1, 1986
Pharmacokinetic aspects of drug therapy in the elderlyD J Greenblatt, D R Abernethy, R I Shader
Journal of Chromatography|March 20, 1987
High-performance liquid chromatographic determination of diltiazem and its major metabolites, N-monodemethyldiltiazem and desacetyldiltiazem, in plasmaS C Montamat, D R Abernethy, J R Mitchell
Journal of Chromatography|July 12, 1985
Diltiazem and desacetyldiltiazem analysis in human plasma using high-performance liquid chromatography: improved sensitivity without derivationD R Abernethy, J B Schwartz, E L Todd
Clinical Pharmacology and Therapeutics|April 1, 1984
Plasma protein binding of drugs after severe burn injuryJ A Martyn, D R Abernethy, D J Greenblatt
Psychopharmacology Bulletin|January 1, 1984
Anxiolytic drug therapy in patients with medical disease: clinical importance of pharmacokinetic drug interactionsD J Greenblatt, R I Shader, D R Abernethy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Metabolite inhibition of parent drug biotransformation. Studies of diltiazemS C Tsao, T H Dickinson, D R Abernethy
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1985
Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugsD S Morse, D R Abernethy, D J Greenblatt
Pageof 23

Showing results (91-100 of 221) with videos related to

Sort By:
Pageof 23
The New England Journal of Medicine|August 11, 1983
Drug therapy. Current status of benzodiazepinesD J Greenblatt, R I Shader, D R Abernethy
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1985
Imipramine and desipramine disposition in the elderlyD R Abernethy, D J Greenblatt, R I Shader
Clinical Pharmacology and Therapeutics|May 1, 1987
The effect of propylene glycol on antipyrine clearance in humansE B Nelson, J M Egan, D R Abernethy
Therapeutic Drug Monitoring|January 1, 1986
Pharmacokinetic aspects of drug therapy in the elderlyD J Greenblatt, D R Abernethy, R I Shader
Journal of Chromatography|March 20, 1987
High-performance liquid chromatographic determination of diltiazem and its major metabolites, N-monodemethyldiltiazem and desacetyldiltiazem, in plasmaS C Montamat, D R Abernethy, J R Mitchell
Journal of Chromatography|July 12, 1985
Diltiazem and desacetyldiltiazem analysis in human plasma using high-performance liquid chromatography: improved sensitivity without derivationD R Abernethy, J B Schwartz, E L Todd
Clinical Pharmacology and Therapeutics|April 1, 1984
Plasma protein binding of drugs after severe burn injuryJ A Martyn, D R Abernethy, D J Greenblatt
Psychopharmacology Bulletin|January 1, 1984
Anxiolytic drug therapy in patients with medical disease: clinical importance of pharmacokinetic drug interactionsD J Greenblatt, R I Shader, D R Abernethy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Metabolite inhibition of parent drug biotransformation. Studies of diltiazemS C Tsao, T H Dickinson, D R Abernethy
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1985
Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugsD S Morse, D R Abernethy, D J Greenblatt
Pageof 23